Prescribe DUPIXENT—the only biologic
indicated for OCS-dependent asthma
OF INSURANCE PLANS REQUIRE
NO BIOMARKER TESTING for
OCS-dependent asthma patients
for DUPIXENT1
DUPIXENT is indicated as an add-on maintenance treatment in patients
with moderate-to-severe asthma aged 12 years and older with an
eosinophilic phenotype or with oral corticosteroid dependent
asthma. Limitation of Use: DUPIXENT is not indicated for the
relief of acute bronchospasm or status asthmaticus.
Start your OCS-dependent asthma
patients on this biologic treatment option